Evidence map›Paper›PMID 32211442›Full record

ArticleJournal of immunology research2020

The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice.

Mohamed L Salem, Sabry A El-Naggar, Maysa A Mobasher, Rehab M Elgharabawy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Mohamed L SalemImmunology and Biotechnology Unit, Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt.
Sabry A El-NaggarImmunology and Biotechnology Unit, Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt.
Maysa A MobasherBiochemistry Division, Department of Pathology, College of Medicine, Jouf University, Sakakah, Saudi Arabia.ORCID https://orcid.org/0000-0003-2987-0387
Rehab M ElgharabawyDepartment of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.ORCID https://orcid.org/0000-0002-4399-8195
Tanta University · EGJouf University · SAQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the activating factors of the cells of the innate immune system is the agonists of toll-like receptors (TLRs). Our earlier publications detailed how poly(I:C), a TLR3 agonist, elevates the NK cell population and the associated antigen-specific CD8

Indexed as

AnimalsAntigens, LyCD11b AntigenCD11c AntigenCell ProliferationCells, CulturedImmunophenotypingKiller Cells, NaturalLiverLymphocyte ActivationLymphocyte CountLymphocyte SubsetsMacrophage-1 AntigenMiceMice, Inbred C57BLMice, KnockoutAntigens, LyCD11b AntigenCD11c AntigenKlrb1c protein, mouseMacrophage-1 AntigenNK Cell Lectin-Like Receptor Subfamily BPoly I-CToll-Like Receptor 3

Identifiers

PMID32211442
PMCPMC7077049
OpenAlexW3009250553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.